|
MSH6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.0465000522284E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.7639999995196E-07 |
| Normal-vs-Stage2 |
8.39869999991194E-07 |
| Normal-vs-Stage3 |
4.43609999845052E-08 |
| Normal-vs-Stage4 |
8.42209999518673E-08 |
| Stage1-vs-Stage2 |
1.133180E-01 |
| Stage1-vs-Stage3 |
1.899240E-01 |
| Stage1-vs-Stage4 |
6.586000E-02 |
| Stage2-vs-Stage3 |
5.484200E-01 |
| Stage2-vs-Stage4 |
9.460200E-01 |
| Stage3-vs-Stage4 |
5.662400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.36590002933701E-09 |
| Normal-vs-AfricanAmerican |
3.431700E-02 |
| Normal-vs-Asian |
2.35060000000065E-05 |
| Caucasian-vs-AfricanAmerican |
1.304040E-01 |
| Caucasian-vs-Asian |
8.404400E-01 |
| AfricanAmerican-vs-Asian |
2.171200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.73840000009073E-07 |
| Normal-vs-Female |
6.65099997299023E-09 |
| Male-vs-Female |
9.867000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.0379999999931E-05 |
| Normal-vs-Age(41-60Yrs) |
5.69780000958531E-09 |
| Normal-vs-Age(61-80Yrs) |
3.73060005109949E-09 |
| Normal-vs-Age(81-100Yrs) |
5.684900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.127700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.721800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.077800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.565600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.784800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.432000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.535700E-02 |
| Classical-VS-Follicular |
1.353790E-04 |
| Classical-VS-Other |
1.806400E-01 |
| Classical-VS-Normal |
1.32210000003408E-06 |
| Tall-VS-Follicular |
5.437600E-01 |
| Tall-VS-Other |
6.948400E-01 |
| Tall-VS-Normal |
1.5005799999912E-05 |
| Follicular-VS-Other |
9.740600E-01 |
| Follicular-VS-Normal |
1.36819999774218E-09 |
| Other-VS-Normal |
4.935700E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.16280002188307E-09 |
| Normal-vs-N1 |
1.48929999999048E-07 |
| N0-vs-N1 |
3.989400E-01 |
|
|
